Keyword: Contract Development And Manufacturing Organizations (CDMO)

Plant Construction & Process Technology

U.S. API Manufacturing and Sustainability

16.01.2014 - Moving Away - Many would argue that the future of pharmaceutical growth in the coming years will come from emerging markets; U.S. pharma sales have been sluggish recently with a...

Chemistry & Life Sciences

PCRAMS is a Booming Business

16.01.2014 - Global Growth - Milan-based Chemical Pharmaceutical Association (CPA) recently published the report "The World Pharmaceutical Contract Research and Manufacturing Services Industry...

Plant Construction & Process Technology

Standing Out in Global Pharmaceutical Contract Manufacturing Market

12.11.2013 - Joining The Supply Chain - Pharmaceutical contract manufacturing used to be viewed as a one-off activity where a pharmaceutical company outsourced a drug for manufacturing...

Plant Construction & Process Technology

Outsourcing Biopharmaceutical Manufacturing

12.11.2013 - Development On Trial - The number of biopharmaceutical projects in clinical trials and products is increasing, playing an important role in new treatments. Many of these projects...

Plant Construction & Process Technology

Double Risk with an Upgrade

31.10.2013 - Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based...

Plant Construction & Process Technology

Sourcing from India and China

30.10.2013 - 'Pharmacy To The World' - In today's global pharmaceutical industry 2.0, emerging regions led by India (BRIC - Brazil, Russia, India, China) have moved to the front row in terms of...

News

Lonza’s Corporate Overhaul

28.10.2013 - Strategic Maneuvers - When Richard Ridinger took over as CEO of Basel, Switzerland-based Lonza in May 2012, the 115-year old life science and chemical company with sales of just...

News

Clariant to Sell Detergents & Intermediates Business to ICIG

24.10.2013 - Clariant has agreed to sell its Detergents & Intermediates business to International Chemical Investors Group (ICIG) for 58 million Swiss francs, including 20 million in cash. The...